<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:media="http://search.yahoo.com/mrss/" 
	>
<channel>
	<title>
	Comments for SeamlessBio	</title>
	<atom:link href="https://seamlessbio.de/comments/feed/" rel="self" type="application/rss+xml" />
	<link>https://seamlessbio.de/</link>
	<description>Expert for biological materials for pharma, vaccines and research organizations</description>
	<lastBuildDate>Wed, 14 Oct 2026 09:08:41 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>
	<item>
		<title>
		Comment on Why Switch to Serum-Free CHO Medium for mAb Production? by dliyatul awliya		</title>
		<link>https://seamlessbio.de/why-switch-to-serum-free-cho-medium-for-mab-production/#comment-74</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 09:08:41 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=9184#comment-74</guid>

					<description><![CDATA[This article highlights how switching to serum-free CHO medium can improve batch consistency, reduce regulatory burdens, and simplify downstream purification in monoclonal antibody production, emphasizing the importance of selecting compatible, chemically defined media for reliable GMP manufacturing.]]></description>
			<content:encoded><![CDATA[<p>This article highlights how switching to serum-free CHO medium can improve batch consistency, reduce regulatory burdens, and simplify downstream purification in monoclonal antibody production, emphasizing the importance of selecting compatible, chemically defined media for reliable GMP manufacturing.</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Comment on Serum-Free HEK293 Medium: AAV Production vs. Lentiviral Vectors — What&#8217;s Different? by dliyatul awliya		</title>
		<link>https://seamlessbio.de/serum-free-hek293-medium-aav-production-vs-lentiviral-vectors-whats-different/#comment-71</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 08:57:57 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=9186#comment-71</guid>

					<description><![CDATA[This article explains how serum-free media requirements differ between AAV and lentiviral vector production, emphasizing the importance of cell line compatibility, transfection efficiency, cell viability, and vector stability in achieving reliable and scalable biopharmaceutical manufacturing.]]></description>
			<content:encoded><![CDATA[<p>This article explains how serum-free media requirements differ between AAV and lentiviral vector production, emphasizing the importance of cell line compatibility, transfection efficiency, cell viability, and vector stability in achieving reliable and scalable biopharmaceutical manufacturing.</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Comment on HEK293T vs. HEK293F vs. HEK293FT: Which Serum-Free Medium Does Each Need? by dliyatul awliya		</title>
		<link>https://seamlessbio.de/hek293t-vs-hek293f-vs-hek293ft-which-serum-free-medium-does-each-need/#comment-70</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 08:55:20 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=9190#comment-70</guid>

					<description><![CDATA[This article explains how different HEK293 cell lines require specific serum-free media based on their genetic characteristics, growth formats, and applications, highlighting the importance of proper medium selection for improving cell viability, transfection efficiency, and biopharmaceutical production.]]></description>
			<content:encoded><![CDATA[<p>This article explains how different HEK293 cell lines require specific serum-free media based on their genetic characteristics, growth formats, and applications, highlighting the importance of proper medium selection for improving cell viability, transfection efficiency, and biopharmaceutical production.</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Comment on Serum-Free Media for ATMP Manufacturing: CHO and HEK293 Side by Side by dliyatul awliya		</title>
		<link>https://seamlessbio.de/serum-free-media-for-atmp-manufacturing-cho-and-hek293-side-by-side/#comment-69</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 08:52:05 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=9192#comment-69</guid>

					<description><![CDATA[This article highlights how smart HV wire winding machines combine automation, process monitoring, and digital traceability to improve manufacturing efficiency, product quality, and production consistency, while showing how Industry 5.0 connects human expertise with advanced technology.]]></description>
			<content:encoded><![CDATA[<p>This article highlights how smart HV wire winding machines combine automation, process monitoring, and digital traceability to improve manufacturing efficiency, product quality, and production consistency, while showing how Industry 5.0 connects human expertise with advanced technology.</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Comment on Animal Sera Guide by dliyatul awliya		</title>
		<link>https://seamlessbio.de/animal-sera-complete-guide/#comment-61</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Mon, 14 Sep 2026 06:12:58 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=3397#comment-61</guid>

					<description><![CDATA[A clear and practical guide to choosing the right animal serum for different research applications. The species-by-species breakdown and quick selection table make it especially useful, while the focus on haemolysis, sterility, mycoplasma, and endotoxin specifications highlights important quality]]></description>
			<content:encoded><![CDATA[<p>A clear and practical guide to choosing the right animal serum for different research applications. The species-by-species breakdown and quick selection table make it especially useful, while the focus on haemolysis, sterility, mycoplasma, and endotoxin specifications highlights important quality</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Comment on Guinea Pig Complement by dliyatul awliya		</title>
		<link>https://seamlessbio.de/guinea-pig-complement-hemolytic-assay-guide/#comment-60</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Mon, 14 Sep 2026 05:19:11 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=3407#comment-60</guid>

					<description><![CDATA[A clear and practical overview of guinea pig complement and its role in hemolytic assays. The sections on CH50 testing, complement handling, storage, and quality specifications provide useful details for maintaining reliable and reproducible assay results.]]></description>
			<content:encoded><![CDATA[<p>A clear and practical overview of guinea pig complement and its role in hemolytic assays. The sections on CH50 testing, complement handling, storage, and quality specifications provide useful details for maintaining reliable and reproducible assay results.</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Comment on Off-the-Clot (OTC) Serum Explained — When &#038; Why to Use It by dliyatul awliya		</title>
		<link>https://seamlessbio.de/off-the-clot-serum-explained/#comment-37</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Tue, 25 Aug 2026 04:33:58 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=2855#comment-37</guid>

					<description><![CDATA[A clear, well-organized comparison of OTC versus standard serum grounded in the actual biology (platelet degranulation and growth factor release), with genuinely useful decision guidance across specific applications  though, like SeamlessBio&#039;s other guides, it&#039;s ultimately structured to sell their own OTC serum product.]]></description>
			<content:encoded><![CDATA[<p>A clear, well-organized comparison of OTC versus standard serum grounded in the actual biology (platelet degranulation and growth factor release), with genuinely useful decision guidance across specific applications  though, like SeamlessBio&#8217;s other guides, it&#8217;s ultimately structured to sell their own OTC serum product.</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		Comment on Human AB Serum — Complete Guide to Uses, Grades &#038; When to Switch by dliyatul awliya		</title>
		<link>https://seamlessbio.de/human-ab-serum-cell-culture-guide/#comment-36</link>

		<dc:creator><![CDATA[dliyatul awliya]]></dc:creator>
		<pubDate>Tue, 25 Aug 2026 04:32:20 +0000</pubDate>
		<guid isPermaLink="false">https://seamlessbio.de/?p=2851#comment-36</guid>

					<description><![CDATA[A technically credible, well-differentiated reference on human AB serum applications with specific, checkable data (IgG concentrations, endotoxin mechanisms), though it&#039;s unmistakably built to sell SeamlessBio&#039;s own serum products.]]></description>
			<content:encoded><![CDATA[<p>A technically credible, well-differentiated reference on human AB serum applications with specific, checkable data (IgG concentrations, endotoxin mechanisms), though it&#8217;s unmistakably built to sell SeamlessBio&#8217;s own serum products.</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
